HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--Nymox Pharmaceutical Corporation (NASDAQ: NYMX) announced today its financial results for the quarter ended September 30, 2007. Nymox reported a net loss of $1,386,084, or $0.05 per share for the third quarter of 2007, compared to $1,238,833, or $0.04 per share for same period in 2006. Product sales amounted to $277,921 for the nine months ending September 30, 2007, compared to $353,962 for the same period in 2006. The weighted average number of common shares at the quarter ended September 30, 2007 was 29,182,571, compared to 27,789,196 at September 30, 2006.
